Log In
BCIQ
Print this Print this
 

NC-2400

  Manage Alerts
Collapse Summary General Information
Company Nippon Chemiphar Co. Ltd.
DescriptionPeroxisome proliferation activated receptor (PPAR) alpha agonist
Molecular Target Peroxisome proliferation activated receptor (PPAR) alpha
Mechanism of ActionPeroxisome proliferation activated receptor (PPAR) alpha agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHyperlipidemia
Indication DetailsTreat hyperlipidemia
Regulatory Designation
PartnerCerenis Therapeutics S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today